PUBLISHER: Inkwood Research | PRODUCT CODE: 1460609
PUBLISHER: Inkwood Research | PRODUCT CODE: 1460609
The Asia-Pacific bariatric surgery market is projected to register a CAGR of 5.93% during the forecast period, 2024-2032. The rising incidence of obesity and medical tourism are propelling market growth in the region.
Australia & New Zealand, Vietnam, China, Japan, Thailand, Indonesia, South Korea, India, and Rest of Asia-Pacific are analyzed for the Asia-Pacific bariatric surgery market growth assessment. Rising obesity rates, coupled with an increasing awareness of the health risks associated with obesity-related conditions such as diabetes and cardiovascular diseases, have spurred the demand for bariatric surgeries in the Asia-Pacific.
Government initiatives aimed at addressing the obesity epidemic and improving healthcare infrastructure have also played a significant role in fueling market growth. Furthermore, advancements in surgical techniques and technologies, including minimally invasive procedures such as laparoscopic surgery and the adoption of innovative surgical systems, have made bariatric surgeries safer and more accessible to a larger patient population.
Moreover, changing lifestyles, urbanization, and dietary habits have contributed to the escalating prevalence of obesity across Asia-Pacific countries, driving the need for effective weight management solutions such as bariatric surgery. Additionally, the growing acceptance of bariatric procedures among both patients and healthcare providers, coupled with increasing disposable incomes, has further propelled market expansion.
Some of the distinguished companies operating in the region are Aspire Bariatrics, Abbott Laboratories, GE Healthcare, Johnson & Johnson (Ethicon, Inc), etc.